Moreover, IGF2BP2 inhibition restrained MTA1 expression in the case of FTO deficiency, suggesting a FTO-IGF2BP2 m6A regulatory mechanism of MTA1 expression in CRC. The gene discussed is FTO; the disease is colorectal carcinoma.